IBEX Technologies Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IBEX Technologies Inc with three other
companies in this sector in CANADA :
VBI Vaccines Inc
(2020
sales of 1.42 million Canadian Dollars [US$1.13 million]
of which 73%
was R&D Service revenue),
Liminal BioSciences Inc
(3.32 million Canadian Dollars [US$2.64 million]
of which 78%
was Plasma derived therapeutics), and
StageZero Life Sciences Ltd
(5.56 million Canadian Dollars [US$4.43 million]
of which 100%
was Developing and commercializing proprieta).
Sales Analysis.
IBEX Technologies Inc reported sales of C$5.21 million (US$4.15 million)
for the
fiscal
year ending
July of 2020.
This
represents
an
increase of 20.9%
versus 2019, when the company's sales were C$4.31 million.